{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:50:14Z","timestamp":1785333014284,"version":"3.55.0"},"reference-count":56,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,3,19]],"date-time":"2010-03-19T00:00:00Z","timestamp":1268956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>Increased oxidative stress and up\u2010regulation of matrix metalloproteinases (MMPs) may cause structural and functional vascular changes in renovascular hypertension. We examined whether treatment with spironolactone (SPRL), hydrochlorothiazide (HCTZ) or both drugs together modified hypertension\u2010induced changes in arterial blood pressure, aortic remodelling, vascular reactivity, oxidative stress and MMP levels and activity, in a model of renovascular hypertension.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>We used the two\u2010kidney,one\u2010clip (2K1C) model of hypertension in Wistar rats. Sham\u2010operated or hypertensive rats were treated with vehicle, SPRL (25\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7day<jats:sup>\u22121<\/jats:sup>), HCTZ (20\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7day<jats:sup>\u22121<\/jats:sup>) or a combination for 8 weeks. Systolic blood pressure was monitored weekly. Aortic rings were isolated to assess endothelium\u2010dependent and \u2010independent relaxations. Morphometry of the vascular wall was carried out in sections of aorta. Aortic NADPH oxidase activity and superoxide production were evaluated. Formation of reactive oxygen species was measured in plasma as thiobarbituric acid\u2010reactive substances. Aortic MMP\u20102 levels and activity were determined by gelatin and<jats:italic>in situ<\/jats:italic>zymography, fluorimetry and immunohistochemistry.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold>Treatment with SPRL, HCTZ or the combination attenuated 2K1C\u2010induced hypertension, and reversed the endothelial dysfunction in 2K1C rats. Both drugs or the combination reversed vascular aortic remodelling induced by hypertension, attenuated hypertension\u2010induced increases in oxidative stress and reduced MMP\u20102 levels and activity.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>SPRL or HCTZ, alone or combined, exerted antioxidant effects, and decreased renovascular hypertension\u2010induced MMP\u20102 up\u2010regulation, thus improving the vascular dysfunction and remodelling found in this model of hypertension.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.00678.x","type":"journal-article","created":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T23:09:35Z","timestamp":1269126575000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase\u20102 activity and expression in a model of renovascular hypertension"],"prefix":"10.1111","volume":"160","author":[{"given":"CS","family":"Ceron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MM","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MF","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MCO","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RF","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JE","family":"Tanus\u2010Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,13]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000154680.44184.01"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2006.01.007"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90006-P"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0022-3565(25)38226-1","article-title":"Ion channel involvement in the acute vascular effects of thiazide diuretics and related compounds","volume":"265","author":"Calder JA","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90244-5"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.2.801"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.10.011"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2009.02.011"},{"key":"e_1_2_8_10_1","first-page":"H2002","article-title":"Transmural pressure induces matrix\u2010degrading activity in porcine arteries ex vivo","volume":"277","author":"Chesler NC","year":"1999","journal-title":"Am J Physiol"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.22.5.665"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200111000-00006"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.117531"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.85.10.906"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.8.670"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2007.06.005"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.5.494"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000204344.90301.7c"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3280112ce5"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.100214"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/hy09t1.096249"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000159937.05502.d1"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000258414.59393.89"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(01)00828-0"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-4642fje"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/clinchem\/34.12.2433","article-title":"Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation","volume":"34","author":"Knight JA","year":"1988","journal-title":"Clin Chem"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199109000-00007"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lab.2005.05.005"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20040920"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000196241.96759.71"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.06.096"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000180753.63183.95"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.10.010"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.925"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2006.02.011"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2007.12"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000078357.92682.EC"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(93)90234-O"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-008-0363-1"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000176236.55322.18"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/152308603764816532"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.32.1.156"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.093450"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.47.120505.105230"},{"issue":"2","key":"e_1_2_8_45_1","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.33549\/physiolres.931402","article-title":"Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of l\u2010NAME hypertensive rats","volume":"56","author":"Sladkova M","year":"2007","journal-title":"Physiol Res"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706700"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2006.01.002"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-004-0696-7"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2003.03930.x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90550-U"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00304.2008"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000034738.79310.06"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.835488"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.15.2027"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1650533"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.32.3.488"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000152701.97426.5f"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.00678.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00678.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T16:35:15Z","timestamp":1739982915000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.00678.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,13]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1476-5381.2010.00678.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00678.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,13]]},"assertion":[{"value":"2010-04-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}